PRAX
Praxis Precision Medicines, Inc.
Key Financials
Operating Income
$-326198000
↓ 63.0%
Revenue
$0
↓ 100.0%
Net Income
$-303268000
↓ 65.9%
Total Assets
$937.9M
↑ 94.1%
EPS (Diluted)
$-13.48
↓ 32.0%
Total Liabilities
$59.8M
↑ 58.7%
Cash & Equivalents
$357.3M
↑ 65.9%
Shareholders' Equity
$878.1M
↑ 97.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PRAX |
| Company Name | Praxis Precision Medicines, Inc. |
| CIK | 1689548 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-300-8460 |